All times indicated in the program are in Central European Time (CET). Click here to convert the time into your time zone.
International Viral Hepatitis Elimination Meeting (IVHEM) 2021
Related Enduring Materials
Final Program
Day 1 - Friday, 3 December 2021
Day 2 - Saturday, 4 December 2021
Welcome
The International Viral Hepatitis Elimination Meeting (IVHEM) took place as a virtual meeting from 3-4 December 2021. Convened in partnership between Virology Education and the Coalition for Global Hepatitis Elimination (CGHE), IVHEM is a global forum for the exchange of practical experiences for translating diagnostic and therapy advances of viral hepatitis into broad applications that accelerate progress towards the elimination of viral hepatitis as a public health threat by 2030.
Hepatitis B and C affect more than 320 million people globally and can lead to liver disease and mortality from liver failure and hepatocellular carcinoma. More than 248 million people (3.8% of the world’s population) are chronically infected with HBV, and over 700,000 attributable deaths annually. An estimated 80 million people (globally, 1.1%) are chronically infected with hepatitis C virus (HCV), resulting in nearly 500,000 deaths annually.
Key issues to be addressed are how to translate research outcomes into public health policy and practice to meet the 2030 elimination targets. During this two day meeting, experts in viral hepatitis from around the globe will examine current evidence on how to implement programs that improve the prevention of viral hepatitis and increase the number of people accessing testing and treatment.
The program includes practical examples of innovative intervention studies, country elimination programs, and novel funding mechanisms for testing and treatment.
We invite you to contribute to the elimination of viral hepatitis and look forward to welcoming you to this unique meeting virtually!
The Organizing Committee
Program Chairs 2021
General Information
We are available to answer any questions or concerns that you may have about your participation. For more information, please contact Christina Dammers via Christina.Dammers@amededu.com
- Clinicians
- Researchers
- Policymakers
- Virologists
- Pharmacologists
- Industry representatives
- Community representatives
- Provide a forum for knowledge exchange and discussion of practical experiences related to the clinical management of viral hepatitis;
- Provide a toolbox for the practical application of research & development for evidence-based policymaking; and
- Facilitate cross-disciplinary discussion on barriers and challenges preventing the elimination of viral hepatitis.
- Identify innovative strategies for hepatitis b and hepatitis C testing and linkage to care and how these can be applied to their program and clinical activities;
- Recognize the needs from a public health perspective and respond to these needs by reshaping their policymaking approaches;
- Further develop new or strengthen already existing foundations for political commitment, national planning, and program improvements; and
- Translate the latest research and technologies into clinical policy and practice for delivering an adequate continuum of viral hepatitis services.
Practical Information
Translation will not be provided.
A 25% discount on the meeting registration fee is offered to the members/employees of our endorsers. Please reach out to your organization for your discount code.
If you would like your organization to endorse IVHEM 2021, please contact Christina Dammers at christina.dammers@amededu.com
Program Chairs 2021
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Committee
-
Rakesh Aggarwal, MD (AIIMS), DM (PGIMER), FNASc, FAMS - Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India
-
Po-Lin Chan, MD - World Health Organization, Philippines
-
Graham Cooke, MD, PhD - Imperial College London, United Kingdom
-
Gagandeep Singh Grover, MD - Health and Family Welfare, India
-
Saeed Hamid, MBBS, FRCP, FRCPI, FACP, FACG, FAASLD - Aga Khan University, Pakistan
-
Angelos Hatzakis, MD, PhD, MSc - Athens University Medical School, Greece
-
Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD - Burnet Institute, Australia
-
Khin Pyone Kyi, MBBS, DBact, MMedSc, PhD, FRCP - Myanmar Liver Foundation, Myanmar
-
Jeffrey Lazarus, PhD, MIH, MA - ISGlobal, Spain
-
Maud Lemoine, MD, PhD - Imperial College London, United Kingdom
-
Liudmyla Maistat - Medicines Patent Pool, Switzerland
-
Hailemichael Desalegn Mekonnen, MD, PhD - St. Paul’s Hospital Millennium Medical College, Ethiopia
-
Yvonne Nartey, MBChB, MSc, MPhil – Cape Coast Teaching Hospital, Ghana
-
Ponsiano Ocama, MD, PhD - Makerere University, Uganda
-
Jean-Michel Pawlotsky, MD, PhD - Hôpital Henri Mondor, France
-
Homie Razavi, PhD, MBA - Center for Disease Analysis (CDA), United States
-
Shiv. K. Sarin, MD, DM, DSc. (Hony.), FNA, FNAS - Institute of Liver and Biliary Sciences (ILBS), India
-
Janvier Serumondo, MD - Rwanda Biomedical Centre, Rwanda
-
Sonjelle Shilton, MPH - Foundation for Innovative New Diagnostics (FIND), Switzerland
-
Mark Sonderup, B Pharm, MBChB, FCP(SA), MMed - University of Cape Town, South Africa
-
Nasamon Wanlapakorn, MD, PhD - Chulalongkorn University, Thailand
The members of Scientific Committee are hand-picked by the Organizing Committee and the workshop secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
IVHEM 2021 is Convened in partnership between Virology Education and the Coalition for Global Hepatitis Elimination (CGHE).
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in the elimination of viral hepatitis.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Karin Siebelt at Karin.Siebelt@amededu.com or call +31 30 230 7149